ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
107,613.95
4.36%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. IGM Biosciences Inc (IGMS) 시세

IGM Biosciences Inc

IGM Biosciences Inc (IGMS)

NASDAQ
1.77
-0.06
(-3.28%)
마감 20 1월 6:00AM
15분 지연
1.77
0.00
(0.00%)
시간외 거래: 9:59AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
1.77
매수가
1.78
매도가
3.61
거래량
320,664
1.75 일간 변동폭 1.91
1.59 52주 범위 22.50
market_cap
105.252M
전일 종가
1.83
개장가
1.88
최근 거래 시간
19
@
1.7604
마지막 거래 시간
재정 규모
US$ 592,994
VWAP
1.8493
평균 볼륨(3m)
414,792
발행 주식
59,464,181
배당수익률
-
주가수익률
-0.43
주당순이익(EPS)
-4.14
매출
2.13M
순이익
-246.42M

IGM Biosciences Inc 정보

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.igmbio.com
본부
Dover, Delaware, USA
설립됨
-
IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker IGMS. The last closing price for IGM Biosciences was US$1.83. Over the last year, IGM Biosciences shares have traded in a share price range of US$ 1.59 to US$ 22.50.

IGM Biosciences currently has 59,464,181 shares in issue. The market capitalisation of IGM Biosciences is US$108.82 million. IGM Biosciences has a price to earnings ratio (PE ratio) of -0.43.

IGMS 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities

18 1월 2025
Edgar (US Regulatory)

Form 8-K - Current report

11 1월 2025
Edgar (US Regulatory)

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

– Company halting further development of imvotamab (CD20 x CD3) and IGM-2644 (CD38 x CD3) – – Company reducing its workforce by 73% – – Cash and investments of $183.8 million (unaudited) as of...

10 1월 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

04 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 12월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 12월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 12월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.2101-10.61057522351.98012.191.5923409671.9803712CS
4-5.08-74.16058394166.857.51.598672372.89913904CS
12-14.13-88.867924528315.918.691.594147925.82827614CS
26-9.9158-84.853411833211.685822.51.593601079.61473039CS
52-7.73-81.36842105269.522.51.593333339.88698373CS
156-19.36-91.623284429721.1335.981.5936756615.80590484CS
260-32.08-94.771048744533.851331.5929303128.62940817CS

IGMS - Frequently Asked Questions (FAQ)

What is the current IGM Biosciences share price?
The current share price of IGM Biosciences is US$ 1.77
How many IGM Biosciences shares are in issue?
IGM Biosciences has 59,464,181 shares in issue
What is the market cap of IGM Biosciences?
The market capitalisation of IGM Biosciences is USD 108.82M
What is the 1 year trading range for IGM Biosciences share price?
IGM Biosciences has traded in the range of US$ 1.59 to US$ 22.50 during the past year
What is the PE ratio of IGM Biosciences?
The price to earnings ratio of IGM Biosciences is -0.43
What is the cash to sales ratio of IGM Biosciences?
The cash to sales ratio of IGM Biosciences is 49.44
What is the reporting currency for IGM Biosciences?
IGM Biosciences reports financial results in USD
What is the latest annual turnover for IGM Biosciences?
The latest annual turnover of IGM Biosciences is USD 2.13M
What is the latest annual profit for IGM Biosciences?
The latest annual profit of IGM Biosciences is USD -246.42M
What is the registered address of IGM Biosciences?
The registered address for IGM Biosciences is CORPORATION TRUST CENTER, 1209 ORANGE ST, DOVER, DELAWARE, 19901
What is the IGM Biosciences website address?
The website address for IGM Biosciences is www.igmbio.com
Which industry sector does IGM Biosciences operate in?
IGM Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

IGMS Discussion

게시물 보기
Monksdream Monksdream 7 월 전
IGMS under $10
👍️0
Monksdream Monksdream 9 월 전
IGMS under $10
👍️0
crudeoil24 crudeoil24 3 년 전
Truist Reiterates Buy Rating, $80 Price Target.
👍️0
crudeoil24 crudeoil24 3 년 전
Let's see if IGMS gets FDA phase I,II,III, approvals . Sanofi believes it'll happen.
👍️0
crudeoil24 crudeoil24 3 년 전
14M float!
👍️0
crudeoil24 crudeoil24 3 년 전
Tons of cash going forward > IGM Biosciences, Inc. (NASDAQ: IGMS) today announced that it intends to offer and sell $200.0 million of shares of its common stock and, in lieu of common stock to certain investors that so choose, non-voting common stock, in an underwritten public offering. In addition, IGM intends to grant the underwriters a 30-day option to purchase up to an additional $30.0 million of shares at the public offering price, less underwriting discounts and commissions. All of the securities offered in the offering will be sold by IGM. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
J.P. Morgan, BofA Securities, Stifel, and Guggenheim Securities are acting as joint book-running managers for the offering.
👍️0
TheFinalCD TheFinalCD 3 년 전
https://ih.advfn.com/stock-market/NASDAQ/igm-biosciences-IGMS/stock-news/87682546/igm-announces-proposed-public-offering

https://www.wsgr.com/print/v2/content/185066/Firm-Advises-IGM-Biosciences%2C-Inc.-on-%24230-Million-Public-Offering.pdf
👍️0

최근 히스토리

NASDAQ
IGMS
IGM Biosciences
BIT
P1BEJ2
BNP Paribas Issuance
NYSE
AZN
AstraZeneca
BIT
P1PW56
BNP Paribas Issuance
BIT
RUS
Mul - Lyxor Msci Russia ...
BIT
NSCIT0050830
Sara Assicurazioni
BIT
P1T2C2
BNP Paribas Issuance
BIT
S27009
Societe Generale Effekten
BIT
P1JZ69
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유